Tesamorelin (TH9507)
Research-Grade GHRH Analogue
Tagline: GH Axis & Lipid Metabolism Research
Product Description
Tesamorelin (scientific designation TH9507) is a synthetic growth hormone–releasing hormone (GHRH) analogue that selectively stimulates the pituitary to secrete growth hormone (GH). It is widely studied for its ability to increase IGF-1 levels, reduce visceral adiposity, and improve metabolic profiles in research models.
Researchers use Tesamorelin in studies exploring GH/IGF-1 axis regulation, fat redistribution, body composition, and metabolic syndrome. Its high specificity for GHRH receptors and well-defined pharmacokinetics make it an excellent tool for endocrine and metabolic research.
For Laboratory and Scientific Research Use Only. Not for Human Consumption.
Why Researchers Choose Tesamorelin
-
Highly Specific GHRH Analogue: Stimulates physiologic GH secretion without desensitizing pituitary receptors.
-
Metabolic Relevance: Well-documented ability to reduce visceral fat and improve lipid profiles in studies.
-
Extended Half-Life: Modified to resist degradation by DPP-IV, allowing once-daily dosing models.
-
Purity & Reliability: ≥98% peptide purity ensures reproducible experimental results.
-
Batch Verified: Identity and potency confirmed for every lot.
Important Note
For laboratory and scientific research only. Not for human consumption, veterinary use, or diagnostic purposes.
